Effects and molecular mechanism of GSTIrisin on lipolysis and autocrine function in 3T3-L1 adipocytes

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Gao, Shanshan ^a   Li, Fangmin ^a   Li, Huimin ^a   Huang, Yibing ^a   Liu, Yu ^a   Chen, Yuxin ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; FATTY ACID BINDING PROTEIN 4; FIBRONECTIN TYPE III DOMAIN CONTAINING PROTEIN 5; GLUCOSE; GLYCEROL; IRISIN; MESSENGER RNA; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; FIBRONECTIN; FNDC5 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

3T3 CELL LINE; ADIPOCYTE; ADIPOSE TISSUE CELL; ARTICLE; AUTOCRINE EFFECT; CELL COUNTING; CONTROLLED STUDY; IN VITRO STUDY; LIPID STORAGE; LIPOLYSIS; MOLECULAR DYNAMICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; 3T3-L1 CELL LINE; ANIMAL; CELL COUNT; CELL DIFFERENTIATION; CHEMISTRY; DRUG EFFECTS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BLOTTING, WESTERN; CELL COUNT; CELL DIFFERENTIATION; ESCHERICHIA COLI; FIBRONECTINS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; LIPOLYSIS; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS;

EID: 84958213641     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147480     Document Type: Article

References (38)

1. Birsoy K, Soukas A, Torrens J, Ceccarini G, Montez J, Maffei M, et al. Cellular program controlling the recovery of adipose tissue mass: an in vivo imaging approach. Proc Natl Acad Sci. 2008; 105: 12985-12990. doi: 10.1073/pnas.0805621105 PMID: 18753616.
2. Poher A-L, Altirriba J, Veyrat-Durebex C, Rohner-Jeanrenaud F. Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance. Front Physiol. 2015; 6. doi: 10.3389/fphys.2015. 00004 PMID: 25688211.
3. Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Role of extracellular matrix remodelling in adipose tissue pathophysiology. Relevance in the development of obesity. Histol Histopathol. 2012; 27: 1515-1528. PMID: 23059882.
4. Busiello RA, Savarese S, Lombardi A. Mitochondrial uncoupling proteins and energy metabolism. Front A single colony was inoculated Physiol. 2015; 6. doi: 10.3389/fphys.2015.00036 PMID: 25713540.
5. Cannon B, Nedergaard J. Brown Adipose tissue: function and physiological significance. Physiol Rev. 2004; 84: 277-359. doi: 10.1152/physrev.00015.2003 PMID: 14715917.
6. Morak M, Schmidinger H, Riesenhuber G, Rechberger GN, Kollroser M, Haemmerle G, et al. Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues. Mol Cell Proteomics. 2012; 11: 1777-1789. doi: 10.1074/mcp. M111.015743 PMID: 22984285.
7. Kinyui L, Lei S. Turning WAT into BAT: a review on regulators controlling the browning of white adipocytes. Biosci Rep. 2013; 33: e00065. doi: 10.1042/BSR20130046 PMID: 23895241.
8. Jun W, Paul C, Bruce S. Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev. 2013; 27: 234-250. doi: 10.1101/gad.211649.112 PMID: 23388824.
9. Aguirre L, Fernández-Quintela A, Arias N, Portillo M. Resveratrol: anti-obesity mechanisms of action. Molecules. 2014; 19: 18632-18655. doi: 10.3390/molecules191118632 PMID: 25405284.
10. Langfort J, Jagsz S, Dobrzyn P, Brzezinska Z, Klapcinska B, Galbo H, et al. Testosterone affects hormone-sensitive lipase (HSL) activity and lipid metabolism in the left ventricle. Biochem Biophys Res Commun. 2010; 399: 670-676. doi: 10.1016/j.bbrc.2010.07.140 PMID: 20691154.
11. Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. AJP Cell Physiol. 2010; 298: C961-C971. doi: 10.1152/ajpcell.00547.2009 PMID: 20107043.
12. Bag S, Ramaiah S, Anbarasu A. fabp4 is central to eight obesity associated genes: a functional gene network-based polymorphic study. J Theor Biol. 2015; 364: 344-354. doi: 10.1016/j.jtbi.2014.09.034 PMID: 25280936.
13. Chmurzyńska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet. 2006; 47: 39-48. PMID: 16424607.
14. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481: 463-468. doi: 10.1038/nature10777 PMID: 22237023.
15. Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014; 63: 514-525. doi: 10.2337/db13-1106 PMID: 24150604.
16. Sanchis-Gomar F, Lippi G, Mayero S, Perez-Quilis C, García-Giménez JL. Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. J Diabetes. 2012; 4: 196. doi: 10.1111/j. 1753-0407.2012.00194.x PMID: 22372821.
17. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belén Crujeiras A, Seoane LM, Casanueva FF, Pardo M. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013; 8: e60563. doi: 10.1371/journal.pone.0060563 PMID: 23593248.
18. Wang C, Wang L, Li W, Yan F, Tian M, Wu C, et al. Irisin has no effect on lipolysis in 3T3-L1 adipocytes or fatty acid metabolism in HepG2 hepatocytes. Endocrine. 2015; 49: 90-96. doi: 10.1007/s12020-014-0458-9 PMID: 25326905.
19. Huh JY, Dincer F, Mesfum E, Mantzoros CS. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int J Obes. 2014; 38: 1538-1544. doi: 10.1038/ijo.2014.42 PMID: 24614098.
20. Mahajan RD, Patra SK. Irisin, a novel myokine responsible for exercise induced browning of white adipose tissue. Indian J Clin Biochem. 2013; 28: 102-103. doi: 10.1007/s12291-012-0255-2 PMID: 24381432.
21. Zhang Y, Guo H, Deis JA, Mashek MG, Zhao M, Ariyakumar D, et al. Lipocalin 2 regulates brown fat activation via a nonadrenergic activation mechanism. J Biol Chem. 2014; 289: 22063-22077. doi: 10.1074/jbc.M114.559104 PMID: 24917675.
22. Rodríguez A, Becerril S, Méndez-Giménez L, Ramírez B, Sáinz N, Catalán V, et al. Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice. Int J Obes. 2015; 39: 397-407. doi: 10.1038/ijo.2014.166 PMID: 25199621.
23. Unger RE, Peters K, Sartoris A, Freese C, Kirkpatrick CJ. Human endothelial cell-based assay for endotoxin as sensitive as the conventional limulus amebocyte lysate assay. Biomaterials. 2014; 35: 3180-3187. doi: 10.1016/j.biomaterials.2013.12.059 PMID: 24456607.
24. Zu L, He J, Jiang H, Xu C, Pu S, Xu G. Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway. J Biol Chem. 2009; 284: 5915-5926. doi: 10.1074/jbc.M807852200 PMID: 19122198.
25. Albrecht E, Norheim F, Thiede B, Holen T, Ohashi T, Schering L, et al. Irisin - a myth rather than an exercise-inducible myokine. Sci Rep. 2015; 5: 8889. doi: 10.1038/srep08889 PMID: 25749243.
26. Hofmann T, Elbelt U, Stengel A. Irisin as a muscle-derived hormone stimulating thermogenesis - A critical update. Peptides. 2014; 54: 89-100. doi: 10.1016/j.peptides.2014.01.016 PMID: 24472856.
27. Villarroya F. Irisin, turning up the heat. Cell Metab. 2012; 15: 277-278. doi: 10.1016/j.cmet.2012.02.010 PMID: 22405065.
28. Arbabi-Ghahroudi M, Jamshid T, Roger M. Prokaryotic expression of antibodies. Cancer and Metastasis Reviews. 2005; 24: 501-519. PMID: 16408159.
29. Zhao X, Li G, Liang S. Several affinity tags commonly used in chromatographic purification. J Anal Methods Chem. 2013; 2013: 1-8. doi: 10.1155/2013/581093 PMID: 24490106.
30. Schumacher MA, Chinnam N, Ohashi T, Shah RS, Erickson HP. The structure of irisin reveals a novel intersubunit-sheet fibronectin type III (FNIII) dimer: implications for receptor activation. J Biol Chem. 2013; 288: 33738-33744. doi: 10.1074/jbc.M113.516641 PMID: 24114836.
31. Song H, Wu F, Zhang Y, Zhang Y, Wang F, Jiang M, et al. Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis. PLoS ONE. 2014; 9: e110273. doi: 10.1371/journal.pone.0110273 PMID: 25338001.
32. Moon H-S, Dincer F, Mantzoros CS. Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism. 2013; 62: 1131-1136. doi: 10.1016/j.metabol.2013.04.007 PMID: 23664146.
33. Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro: Irisin suppresses malignant breast epithelial growth dynamics. Int J Cancer. 2015; 136: E197-E202. doi: 10.1002/ijc. 29142 PMID: 25124080.
34. Zhang H-J, Zhang X-F, Ma Z-M, Pan L-L, Chen Z, Han H-W, et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol. 2013; 59: 557-562. doi: 10.1016/j.jhep. 2013.04.030 PMID: 23665283.
35. Furuhashi M, Furuhashi M, Saitoh S, Shimamoto K, Miura T. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clin Med Insights Cardiol. 2014;suppl.3: : 23-33. PMID: 25674026.
36. Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, et al. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci U S A. 2015; 112: 12157-12162. doi: 10.1073/pnas. 1516622112 PMID: 26374841.
37. Vaughan RA, Gannon NP, Barberena MA, Garcia-Smith R, Bisoffi M, Mermier CM, Conn CA, Trujillo KA. Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab. 2014; 16: 711-718. doi: 10.1111/dom.12268 PMID: 24476050.
38. Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1-Fndc5 pathway in muscle. FASEB J. 2013; 27: 1981-1989. doi: 10.1096/fj. 12-225755 PMID: 23362117.